The main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special circumstance of ambulant chemotherapy. onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective. Secondary objectives are the evaluation of the safety and tolerability of Doce onkovis. To this purpose data regarding co medications and adverse events are also collected.
Study Type
OBSERVATIONAL
Enrollment
371
Practice
Berlin, Germany
Practice
Brandenburg, Germany
the quantity of Doce onkovis needed pro treatment cycle
Determine the quantity of Doce onkovis needed pro treatment cycle
Time frame: the time the participants will be followed depends on the number of treatment cycles; that means the time frame may extend up to 24 weeks (8 cycles).
adverse events during and after treatment
The number and kind of adverse events during and after the intra-venous application of Docetaxel will be assessed and documented.
Time frame: up to 24 weeks (8 cycles)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Practice
Chemnitz, Germany
Practice
Cottbus, Germany
Practice
Dresden, Germany
Practice
Elstra, Germany
Practice
Freital, Germany
Practice
Fürstenwalde, Germany
Practice
Halle, Germany
Practice
Köthen, Germany
...and 13 more locations